Improving care for heart failure patients
Evaluation and Management of Heart Failure Patients
This study is trying to improve care for adults with severe heart failure by tracking their treatment and health over time to help them feel better and stay out of the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Locations | 1 site (Tel Aviv) |
| Trial ID | NCT03142659 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the understanding and management of heart failure (HF) patients by establishing a registry of individuals evaluated at the Heart Failure unit or clinic. The study focuses on patients aged 18 and older who are experiencing severe HF symptoms, specifically those classified as New York Heart Association Function III-IV. Through regular evaluations by healthcare professionals, including nurses and cardiologists, the study seeks to monitor treatment responses and improve patient quality of life while reducing hospitalization rates. Blood tests and necessary intravenous treatments will be administered as part of the patient care process.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are being evaluated for heart failure at the designated clinic.
Not a fit: Patients who do not provide informed consent or are not evaluated in the Heart Failure unit will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved quality of life and reduced hospitalizations for heart failure patients.
How similar studies have performed: Other studies have shown success in managing heart failure through structured follow-up and registry approaches, indicating potential for positive outcomes in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years old 2. Patient evaluated in the Heart Failure unit or clinic in our facility. 3. Approved consent. Exclusion Criteria: 1\. Patients who haven't signed the informed consent in the prospective group.
Where this trial is running
Tel Aviv
- Tel Aviv Medical Center — Tel Aviv, Israel (Recruiting)
Study contacts
- Principal investigator: Michal Laufer Perl, MD — Tel Aviv Medical Center
- Study coordinator: Michal Laufer Perl, MD
- Email: michalpela@gmail.com
- Phone: 972527360430
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.